INTRALASE FS2
Report
- Report Number
- 3006695864-2018-00003
- Event Type
- Injury
- Date Received
- January 2, 2018
- Date of Event
- December 1, 2017
- Report Date
- March 2, 2018
- Manufacturer
- ABBOTT MEDICAL OPTICS
- Product Code
- HNO
- PMA / PMN Number
- K060372
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KY, US
- Reporter Occupation
- PHYSICIAN
Narratives
ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT MEDICAL OPTICS HAS BEEN SUBMITTED.
IN INITIAL REPORT, THE REPORTED ISSUE WAS INDICATED AS AFFECTING THE LEFT EYE (OS), HOWEVER, THE CORRECT EYE IS THE RIGHT EYE(OD). A RECORD REVIEW WAS PERFORMED. A PRODUCT DEFICIENCY REVIEW WAS PERFORMED AND THERE IS NO PRODUCT DEFICIENCY IDENTIFIED. A DOCUMENT, SERVICE HISTORY, AND TRENDING WAS REVIEWED. THERE IS NOT A RECOGNIZABLE ADVERSE TREND. THE RISKS AND MITIGATIONS ASSOCIATED WITH THE COMPLAINT ISSUE ARE IDENTIFIED IN EXISTING RISK DOCUMENTS AND NO NEW RISKS WERE IDENTIFIED AS PART OF THIS INVESTIGATION. A LABELING REVIEW WAS CONDUCTED; THE OPERATOR MANUAL FOR THE SYSTEM WAS REVIEWED AND FOUND TO INCLUDE ADEQUATE INSTRUCTIONS FOR USE, WARNINGS AND OPERATIONAL ERRORS. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT MEDICAL OPTICS HAS BEEN SUBMITTED.
IN THE INITIAL REPORT, ¿REQUIRED INTERVENTION¿ WAS INADVERTENTLY SELECTED, HOWEVER, ¿OTHER SERIOUS¿ IS THE CORRECT OUTCOME ATTRIBUTED TO ADVERSE EVENT FOR THIS REPORT. ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC. HAS BEEN SUBMITTED.
THE SURGERY CENTER REPORTED THAT A LASER VISION CORRECTION PATIENT WAS EXPERIENCED LOSS OF BEST CORRECTED VISUAL ACUITY AND BLURRED VISION ON THE LEFT EYE (OS) AT A 5 MONTH POST OP EXAM. A BRIEF DESCRIPTION FROM THE SURGERY CENTER INDICATED THE PATIENT GOT WOOD PULP IN EYE 4 DAYS PRIOR TO COMING IN TO THE POST OP EXAM. THE PATIENT¿S CHIEF COMPLAINT WAS OF IRRITATION AND BLUR FROM A FOREIGN BODY. THE SURGERY CENTER REPORTED A LOSS OF BEST CORRECTED VISUAL ACUITY (BCVA) AND THAT THE EVENT IS LASTING AND DISABLING, SIGNIFICANTLY INTERFERING WITH DAILY ACTIVITIES. AT THIS TIME, THE PATIENT IS STILL BEING MANAGED. BCVA FROM (B)(6) 2017: RIGHT EYE PRE-OP 20/20 2.25 X -.25 X 85; LEFT EYE PRE-OP 20/20 2.25 X -.25 X 75. BCVA FROM (B)(6) 2017: RIGHT EYE POST-OP 20/20 -.25 X .00 X 90; LEFT EYE POST-OP 20/20 -2.25 X .00 X 90. BCVA FROM (B)(6) 2017: RIGHT EYE POST-OP 20/40 ; LEFT EYE POST-OP 20/20.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 367 | INTRALASE FS2 | FEMTOSECOND LASER | HNO | ABBOTT MEDICAL OPTICS | 20003D |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 60 YR | Other| R | WAVELIGHT SERIAL NO. (B)(4) |